| Theme | New Strategies to Control Viral Hepatitis in Dialysis Patients | |
|---|---|---|
| Title | Influence of hepatitis infection on hemodialysis patients | |
| Publish Date | 2009/08 | |
| Author | Chifumi Sato | Department of Analytical Health Science, Graduate School of Health Care Sciences, Tokyo Medical & Dental University |
| Author | Hiroko Ishikawa | School of HealthCare Sciences, Tokyo Medical & Dental University |
| Author | Happei Miyakawa | Health Care Center, Ibaraki University |
| [ Summary ] | The prevalence of HBsAg in hemodialysis patients was 3%, which was higher than the 1.3% reported in the general population. The prevalence of anti-HBs was also highly suspect in transmission through blood transfusion and other treatments. The prevalence of anti-HCV in hemodialysis patients was 24% in 1994, which was much higher than the 1.2% observed in the general population. It then decreased to 9.84% in 2007. Several reports have suggested that the prognosis for HCV-positive patients is worse than for HCV-negative patients whether they have apparent liver injury or not. The prognosis for these patients after interferon therapy is not clear. | |